Ticker name:MIRAMIRA PHARMACEUTICALS, INC.

Country: US-Sector: Healthcare, Industry: Drug Manufacturers - General

MIRA Pharmaceuticals, Inc. operates as a biopharmaceutical enterprise currently in the clinical development phase. Its main objective involves the creation and market introduction of a novel synthetic tetrahydrocannabinol (THC) analog. This compound is undergoing investigation for its potential to address anxiety and the cognitive impairments frequently observed in adult patients suffering from early-stage dementia. The firm's lead candidate, MIRA1a, is a synthetic cannabinoid analog engineered to alleviate both anxiety and chronic pain through its interaction with cannabinoid type 1 and type 2 receptors. Originally established in 2020 as MIRA1a Therapeutics, Inc., MIRA Pharmaceuticals, Inc. maintains its headquarters in Baltimore, Maryland.

Market Cap 24M

Last close 0.561$

Key metrics

Largest 18 companies In Drug Manufacturers - General

# PositionTickerCompany NameMarket CapLast PriceAction
1LLYELI LILLY & Co1.3T1417.99$
2JNJJOHNSON & JOHNSON665B276.32$
3ABBVAbbVie Inc.521B294.83$
4MRKMerck & Co., Inc.371B150.36$
5NVSNOVARTIS AG315B164.98$
6AZNASTRAZENECA PLC293B189.01$
7AMGNAMGEN INC259B478.48$
8GILDGILEAD SCIENCES, INC.216B174.48$
9PFEPFIZER INC175B30.79$
10BMYBRISTOL MYERS SQUIBB CO131B64.19$
11SNYSanofi116B47.47$
12BIIBBIOGEN INC.38B254.46$
13ZTSZoetis Inc.37B89.2$
14OGNOrganon & Co.3.6B13.83$
15CTORCITIUS ONCOLOGY, INC.51M0.547$
16MIRAMIRA PHARMACEUTICALS, INC.24M0.561$
17SRXHSRX Global Inc.18M0.8871$
18SCLXScilex Holding Co16M1.83$